The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37.

Saved in:
Bibliographic Details
Title: The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37.
Authors: Ianni E; GSK, Siena, Italy. Electronic address: elvira.x.ianni@gsk.com., Stranges D; GSK, Siena, Italy., O'Hagan DT; GSK, Cambridge, MA, United States.
Source: Current opinion in virology [Curr Opin Virol] 2026 Jul 10; Vol. 77, pp. 101568. Date of Electronic Publication: 2026 Jul 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101560941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-6265 (Electronic) Linking ISSN: 18796257 NLM ISO Abbreviation: Curr Opin Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-6265
DOI:10.1016/j.coviro.2026.101568